CA2575407A1 - Nanoparticles and method for the production thereof - Google Patents

Nanoparticles and method for the production thereof Download PDF

Info

Publication number
CA2575407A1
CA2575407A1 CA002575407A CA2575407A CA2575407A1 CA 2575407 A1 CA2575407 A1 CA 2575407A1 CA 002575407 A CA002575407 A CA 002575407A CA 2575407 A CA2575407 A CA 2575407A CA 2575407 A1 CA2575407 A1 CA 2575407A1
Authority
CA
Canada
Prior art keywords
nanoparticles
gelatin
weight
less
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002575407A
Other languages
English (en)
French (fr)
Inventor
Michael Ahlers
Conrad Coester
Klaus Zwiorek
Jan Zillies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gelita AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2575407A1 publication Critical patent/CA2575407A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Jellies, Jams, And Syrups (AREA)
CA002575407A 2004-08-20 2005-08-18 Nanoparticles and method for the production thereof Abandoned CA2575407A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004041340A DE102004041340A1 (de) 2004-08-20 2004-08-20 Nanopartikel und Verfahren zu deren Herstellung
DE102004041340.1 2004-08-20
PCT/EP2005/008954 WO2006021367A1 (de) 2004-08-20 2005-08-18 Nanopartikel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
CA2575407A1 true CA2575407A1 (en) 2006-03-02

Family

ID=35276582

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002575407A Abandoned CA2575407A1 (en) 2004-08-20 2005-08-18 Nanoparticles and method for the production thereof

Country Status (14)

Country Link
US (1) US20080003292A1 (enExample)
EP (1) EP1793810A1 (enExample)
JP (1) JP2008510688A (enExample)
KR (1) KR20070046850A (enExample)
CN (1) CN1988892A (enExample)
AU (1) AU2005276675A1 (enExample)
BR (1) BRPI0514524A (enExample)
CA (1) CA2575407A1 (enExample)
DE (1) DE102004041340A1 (enExample)
IL (1) IL180954A0 (enExample)
MX (1) MX2007001996A (enExample)
NO (1) NO20071458L (enExample)
NZ (1) NZ551326A (enExample)
WO (1) WO2006021367A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006325225B2 (en) 2005-12-14 2013-07-04 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2007072982A1 (en) * 2005-12-20 2007-06-28 Fujifilm Corporation Protein nanoparticles and the use of the same
JP2007224012A (ja) * 2006-01-30 2007-09-06 Fujifilm Corp 酵素架橋したタンパク質ナノ粒子
SI2032592T1 (sl) 2006-06-12 2013-10-30 Cytos Biotechnology Ag Postopki za pakiranje oligonukleotidov v virusu-podobne delce RNA bakteriofagov
JP2008001764A (ja) * 2006-06-21 2008-01-10 Gunma Univ タンパク質からなる粒子状成形体の製造方法及び、該方法により得られたタンパク質からなる粒子状成形体
JP5275561B2 (ja) * 2006-10-30 2013-08-28 富士フイルム株式会社 水分散可能なナノ粒子
DE602007002784D1 (de) * 2007-03-16 2009-11-26 Univ Nat Chi Nan Bioabbaubares Material mit Nanoporen und elektrischer Leitfähigkeit sowie Herstellungsverfahren dafür
JP2008260705A (ja) * 2007-04-11 2008-10-30 Fujifilm Corp 注射用組成物
JP2008297241A (ja) * 2007-05-31 2008-12-11 Fujifilm Corp ニキビ用皮膚外用剤
DE102007041625A1 (de) * 2007-09-03 2009-03-05 Sinn, Hannsjörg, Dr. Neue Gelatine-Wirkstoff-Konjugate
US9724367B2 (en) * 2010-11-10 2017-08-08 Regenmed (Cayman) Ltd. Injectable formulations for organ augmentation
EP2540287A1 (en) 2011-07-01 2013-01-02 FutureChemistry Continuous flow production of gelatin nanoparticles
DE102011052396A1 (de) * 2011-08-04 2013-02-07 Gelita Ag Verfahren zur Herstellung einer stabilen Dispersion von Nanopartikeln, hergestellte Dispersion und deren Verwendung
JP6851987B2 (ja) * 2015-12-25 2021-03-31 コニカミノルタ株式会社 ゼラチン粒子、ゼラチン粒子の製造方法、ゼラチン粒子内包細胞、およびゼラチン粒子内包細胞の製造方法
US11207258B2 (en) 2016-01-25 2021-12-28 Suntory Holdings Limited Capsule containing functional substance and method for manufacturing said capsule
CN107376008B (zh) 2017-07-21 2019-10-22 深圳华诺生物科技有限公司 一种无机纳米颗粒-明胶核壳结构复合材料颗粒的制备方法
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
WO2021146240A1 (en) 2020-01-13 2021-07-22 Cargill, Incorporated Turkey collagen hydrolysates and methods of making
EP3954399B1 (en) * 2020-04-09 2023-11-15 Plmicromed Co., Ltd. Microbeads for embolization and composition for treating proliferative diseases
KR102386631B1 (ko) * 2020-04-09 2022-04-15 주식회사 피엘마이크로메드 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물
KR102645182B1 (ko) * 2021-08-23 2024-03-07 전남대학교산학협력단 젤라틴 가교입자의 제조 방법
KR102861315B1 (ko) * 2022-07-26 2025-09-18 전남대학교산학협력단 작물 생장 촉진용 조성물
US20240049705A1 (en) * 2022-07-26 2024-02-15 Industry Foundation Of Chonnam National University Composition for enhancing growth of plants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
AU671965B2 (en) * 1991-12-05 1996-09-19 Alfatec-Pharma Gmbh Pharmaceutically Applicable Nanosol and Process for Preparing The Same
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140195C2 (de) * 1991-12-05 1994-10-27 Alfatec Pharma Gmbh Pharmazeutisch applizierbares Nanosol und Verfahren zu seiner Herstellung
DE19838189A1 (de) * 1998-08-24 2000-03-02 Basf Ag Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Verfahren zu deren Herstellung
DE60024791T2 (de) * 1999-04-08 2006-07-06 The Johns Hopkins University Antigen-spezifische induktion der peripheren immuntoleranz
US7713551B2 (en) * 2002-09-11 2010-05-11 Elan Pharma International Ltd. Gel stabilized nanoparticulate active agent compositions
CA2435632A1 (en) * 2003-07-21 2005-01-21 Warren Hugh Finlay Formulation of powder containing nanoparticles for aerosol delivery to the lung

Also Published As

Publication number Publication date
KR20070046850A (ko) 2007-05-03
EP1793810A1 (de) 2007-06-13
BRPI0514524A (pt) 2008-06-10
IL180954A0 (en) 2007-07-04
NO20071458L (no) 2007-03-19
US20080003292A1 (en) 2008-01-03
NZ551326A (en) 2010-04-30
AU2005276675A1 (en) 2006-03-02
CN1988892A (zh) 2007-06-27
DE102004041340A1 (de) 2006-02-23
WO2006021367A1 (de) 2006-03-02
MX2007001996A (es) 2007-05-10
JP2008510688A (ja) 2008-04-10

Similar Documents

Publication Publication Date Title
US20080003292A1 (en) Nanoparticles and method for the production thereof
Lammel et al. Recombinant spider silk particles as drug delivery vehicles
Lankalapalli et al. Polyelectrolyte complexes: A review of their applicability in drug delivery technology
Fraunhofer et al. Asymmetrical flow field-flow fractionation and multiangle light scattering for analysis of gelatin nanoparticle drug carrier systems
Iemma et al. pH-Sensitive hydrogels based on bovine serum albumin for oral drug delivery
ES2204837T3 (es) Metodo para la preparacion de microesferas que contienen sistemas coloidales.
Curcio et al. Grafted thermo-responsive gelatin microspheres as delivery systems in triggered drug release
Espinoza et al. Radiation synthesis of seroalbumin nanoparticles
KR20070083927A (ko) 젤 입자의 형태유지 응집체를 형성하는 방법 및 그 용도
Patton et al. Engineering temperature-sensitive hydrogel nanoparticles entrapping hemoglobin as a novel type of oxygen carrier
Stolnik et al. The preparation of sub-200 nm biodegradable colloidal particles from poly (β-malic acid-co-benzyl malate) copolymers and their surface modification with Poloxamer and Poloxamine surfactants
van Hell et al. Stabilization of peptide vesicles by introducing inter-peptide disulfide bonds
Thalhammer-Thurner et al. Albumin-based nanoparticles: small, uniform and reproducible
JP4599550B2 (ja) ナノゲル工学によるハイブリッドゲルの調製とバイオマテリアル応用
Iemma et al. Synthesis and release profile analysis of thermo-sensitive albumin hydrogels
JP4641721B2 (ja) 生物活性物質を担持するためのもしくは担持した微小粒子を含む組成物、ならびにそれらの調製方法
Curcio et al. Negative thermo-responsive microspheres based on hydrolyzed gelatin as drug delivery device
Elaine et al. Advancing Drug Delivery with Biodegradable Molecularly Imprinted Polymers: From Design to Clinical Prospects
JP4665131B2 (ja) 高分子電解質複合体およびその製造方法
Altimari et al. pH‐sensitive drug delivery systems by radical polymerization of gelatin derivatives
Won et al. Preparation and cytotoxicity comparison of type A gelatin nanoparticles with recombinant human gelatin nanoparticles
Madgulkar et al. In vitro and in vivo studies on chitosan beads of losartan duolite AP143 complex, optimized by using statistical experimental design
HK1107762A (en) Nanoparticles and method for the production thereof
Jana et al. Chitosan-based interpenetrating polymer networks: Drug delivery application
Hakkoymaz et al. Both pH and temperature-sensitive copolymer nanogels for controlled release of doxorubicin

Legal Events

Date Code Title Description
FZDE Discontinued